Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

BioInvent receives $3m payment for antibodies selected by Pfizer

December 23, 2020 Research and Development BioInvent, Cancer, Pfizer

BioInvent International, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, …
News
european_commission_web

Zogenix gets EU marketing authorisation for anti-seizure drug

December 23, 2020 Research and Development

The European Commission (EC) has granted marketing authorisation for Zogenix’s FINTEPLA (fenfluramine), an oral solution for the treatment of seizures …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 23, 2020 Research and Development COVID-19, Vaccine

The United States’ mission to inoculate its population is well underway this week; not only has the FDA given emergency …
News

Vicore Pharma study suggests C21 could complement COVID-19 vaccines

December 23, 2020 Research and Development COVID-19, Vicore Pharma

Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …
News
1517679969844

Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.

December 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …
Appointment

The importance of ethics and patient centricity in managed and early access programmes

December 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …
Feature
1516998199715

4BIO Capital appoints Akiko Iwasaki to its Scientific Advisory Board

December 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed …
Appointment
stanley_crooke

Ionis founder Stanley T Crooke to retire

December 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ionis Pharmaceuticals has announced that its founder, Dr Stanley T Crooke, will retire from the company and its board of …
Appointment
barry-green-headshot

Sage Therapeutics appoints Barry Greene as CEO

December 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sage Therapeutics, a biopharmaceutical company focused on developing treatments for central nervous system disorders, has appointed Barry Greene as Chief …
Appointment
top10

Top Ten most popular articles on Pharmafile.com this week

December 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, antibody

The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the …
News
1_1

Samsung Biologics names John Rim as CEO and President

December 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung BioLogics

Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the …
Appointment
nice_new_london_office_internal_3_web

NICE recommends Novartis’ Beovu for wet age-related macular degeneration

December 16, 2020 Research and Development NICE, Novartis, wet AMD Beovu

NICE has published its final appraisal of Novartis’ Beovu (brolucizumab), recommending that the drug be made available via the NHS …
News

Quarter of the world may not access COVID-19 vaccine until 2022

December 16, 2020 Research and Development COVID-19, Vaccine

Almost a quarter of the world’s population may not have access to a COVID-19 vaccine until 2022, according to a …
News
abbvie_0

AbbVie buys COVID-19 antibody licence from Harbour BioMed

December 16, 2020 Research and Development AbbVie, COVID-19, Harbour BioMed, antibody

Harbour BioMed (HBM) and Utrecht University (UU) have announced that their fully human, SARS-CoV-2 neutralising antibody 47D11 and programme, has …
News
dw-anzcxqaqavhl

FDA panel backs Novartis’ Entresto for different form of heart disease

December 16, 2020 Research and Development FDA, Novartis, heart failure

Novartis’ heart failure drug Entresto has received recommendation from the FDA’s Cardiovascular and Renal Drugs Advisory Committee for use in …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026